<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/E/Erythropoietin.xml">
<title>Erythropoietin RSS : Gourt</title>
<link>http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/E/Erythropoietin.xml</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2009-11-06T20:05+36:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Erythropoietin RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://twitter.com/bloodmgmt/statuses/5484204871" />
  <rdf:li rdf:resource="http://twitter.com/PharmacoBlogie/statuses/5476178857" />
  <rdf:li rdf:resource="http://twitter.com/medecinelitt/statuses/5474972758" />
  <rdf:li rdf:resource="http://twitter.com/medicinelitt/statuses/5473874897" />
  <rdf:li rdf:resource="http://twitter.com/medicalcloud/statuses/5437695234" />
  <rdf:li rdf:resource="http://twitter.com/lunggr/statuses/5433680584" />
  <rdf:li rdf:resource="http://twitter.com/sejinhwang/statuses/5376858775" />
  <rdf:li rdf:resource="http://twitter.com/Joe_McNamara/statuses/5360645580" />
  <rdf:li rdf:resource="http://twitter.com/renalandurology/statuses/5297118954" />
  <rdf:li rdf:resource="http://twitter.com/renalandurology/statuses/5296521840" />
  <rdf:li rdf:resource="http://twitter.com/renalandurology/statuses/5268798655" />
  <rdf:li rdf:resource="http://twitter.com/renalandurology/statuses/5268592016" />
  <rdf:li rdf:resource="http://twitter.com/scotttannehill/statuses/5236801053" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://twitter.com/bloodmgmt/statuses/5484204871">
<title>NEJM -- A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia http://ow.ly/zUSv</title>
<link>http://twitter.com/bloodmgmt/statuses/5484204871</link>
<description><![CDATA[NEJM -- A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia http://ow.ly/zUSv]]></description>
</item>

<item rdf:about="http://twitter.com/PharmacoBlogie/statuses/5476178857">
<title>A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia. in NEJM, Nov 5 2009 http://bit.ly/4dQrvs #pharmacology</title>
<link>http://twitter.com/PharmacoBlogie/statuses/5476178857</link>
<description><![CDATA[A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia. in NEJM, Nov 5 2009 http://bit.ly/4dQrvs #pharmacology]]></description>
</item>

<item rdf:about="http://twitter.com/medecinelitt/statuses/5474972758">
<title>#NEJM: A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia: Background: We investig.. http://bit.ly/1dKIlI</title>
<link>http://twitter.com/medecinelitt/statuses/5474972758</link>
<description><![CDATA[#NEJM: A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia: Background: We investig.. http://bit.ly/1dKIlI]]></description>
</item>

<item rdf:about="http://twitter.com/medicinelitt/statuses/5473874897">
<title>#NEJM : A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia: Background: We invest.. http://bit.ly/1dKIlI</title>
<link>http://twitter.com/medicinelitt/statuses/5473874897</link>
<description><![CDATA[#NEJM : A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia: Background: We invest.. http://bit.ly/1dKIlI]]></description>
</item>

<item rdf:about="http://twitter.com/medicalcloud/statuses/5437695234">
<title>&#xE8;&#xB5;&#xA4;&#xE8;&#xA1;&#x80;&#xE7;&#x90;&#x83;&#xE7;&#x99;&#x86;&#xE6;&#xB2;&#xBB;&#xE7;&#x99;&#x82;&#xEF;&#xBC;&#x9A;&#xE3;&#x80;&#x80;&#xE5;&#x90;&#x88;&#xE6;&#x88;&#x90;&#xE3;&#x82;&#xA8;&#xE3;&#x83;&#xAA;&#xE3;&#x82;&#xB9;&#xE3;&#x83;&#xAD;&#xE3;&#x83;&#x9D;&#xE3;&#x82;&#xA4;&#xE3;&#x82;&#xA8;&#xE3;&#x83;&#x81;&#xE3;&#x83;&#xB3;&#xE5;&#x8F;&#x97;&#xE5;&#xAE;&#xB9;&#xE4;&#xBD;&#x93;&#xE3;&#x82;&#xA2;&#xE3;&#x82;&#xB4;&#xE3;&#x83;&#x8B;&#xE3;&#x82;&#xB9;&#xE3;&#x83;&#x88;&#xEF;&#xBC;&#x9A;Hematide: 
novel, synthetic, peptide-based erythropoietin-receptor agonist (Hemati.. http://bit.ly/185dEB</title>
<link>http://twitter.com/medicalcloud/statuses/5437695234</link>
<description><![CDATA[赤血球癆治療：　合成エリスロポイエチン受容体アゴニスト：Hematide: 
novel, synthetic, peptide-based erythropoietin-receptor agonist (Hemati.. http://bit.ly/185dEB]]></description>
</item>

<item rdf:about="http://twitter.com/lunggr/statuses/5433680584">
<title>A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia http://ff.im/-aZQK3</title>
<link>http://twitter.com/lunggr/statuses/5433680584</link>
<description><![CDATA[A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia http://ff.im/-aZQK3]]></description>
</item>

<item rdf:about="http://twitter.com/sejinhwang/statuses/5376858775">
<title>Erythropoietin - it stimulates RBC production in bone marrow TX anaemia for CRF patiens http://tumblr.com/xoj3to69b</title>
<link>http://twitter.com/sejinhwang/statuses/5376858775</link>
<description><![CDATA[Erythropoietin - it stimulates RBC production in bone marrow TX anaemia for CRF patiens http://tumblr.com/xoj3to69b]]></description>
</item>

<item rdf:about="http://twitter.com/Joe_McNamara/statuses/5360645580">
<title>Abstract | Erythropoietin: a multimodal neuroprotective agent http://post.ly/BIBx</title>
<link>http://twitter.com/Joe_McNamara/statuses/5360645580</link>
<description><![CDATA[Abstract | Erythropoietin: a multimodal neuroprotective agent http://post.ly/BIBx]]></description>
</item>

<item rdf:about="http://twitter.com/renalandurology/statuses/5297118954">
<title>Elevated Hepcidin Linked to Low Erythropoietin Levels : High levels of circulating hepcidin are associated with.. http://bit.ly/3W1s76</title>
<link>http://twitter.com/renalandurology/statuses/5297118954</link>
<description><![CDATA[Elevated Hepcidin Linked to Low Erythropoietin Levels : High levels of circulating hepcidin are associated with.. http://bit.ly/3W1s76]]></description>
</item>

<item rdf:about="http://twitter.com/renalandurology/statuses/5296521840">
<title>#RenalWeek2009 Elevated Hepcidin Linked to Low Erythropoietin Levels : High levels of circulating.. http://bit.ly/2YWmHY</title>
<link>http://twitter.com/renalandurology/statuses/5296521840</link>
<description><![CDATA[#RenalWeek2009 Elevated Hepcidin Linked to Low Erythropoietin Levels : High levels of circulating.. http://bit.ly/2YWmHY]]></description>
</item>

<item rdf:about="http://twitter.com/renalandurology/statuses/5268798655">
<title>#RenalWeek2009 Lower Cumulative Erythropoietin EPO Doses Linked to Worse Survival: Lower cumulati.. http://bit.ly/10y5dn</title>
<link>http://twitter.com/renalandurology/statuses/5268798655</link>
<description><![CDATA[#RenalWeek2009 Lower Cumulative Erythropoietin EPO Doses Linked to Worse Survival: Lower cumulati.. http://bit.ly/10y5dn]]></description>
</item>

<item rdf:about="http://twitter.com/renalandurology/statuses/5268592016">
<title>Lower Cumulative Erythropoietin EPO Doses Linked to Worse Survival: Lower cumulative erythropoietin (EPO) doses.. http://bit.ly/4y2o2W</title>
<link>http://twitter.com/renalandurology/statuses/5268592016</link>
<description><![CDATA[Lower Cumulative Erythropoietin EPO Doses Linked to Worse Survival: Lower cumulative erythropoietin (EPO) doses.. http://bit.ly/4y2o2W]]></description>
</item>

<item rdf:about="http://twitter.com/scotttannehill/statuses/5236801053">
<title>Nephrogenic Systemic Fibrosis in Rats Treated with Erythropoietin and Intravenous Iron [Experimental Studies] http://ff.im/-aEFed</title>
<link>http://twitter.com/scotttannehill/statuses/5236801053</link>
<description><![CDATA[Nephrogenic Systemic Fibrosis in Rats Treated with Erythropoietin and Intravenous Iron [Experimental Studies] http://ff.im/-aEFed]]></description>
</item>

</rdf:RDF>